Mirae Asset Global Investments Co., Ltd. Eq Rx, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$1.66 - $2.31 $6,570 - $9,142	-3,958 Reduced 12.29%	28,258 $62,000
Q2 2023 Aug 10, 2023	SELL	$1.61 - $1.96 $34,774 - $42,334	-21,599 Reduced 40.14%	32,216 $59,000
Q1 2023 May 04, 2023	BUY	$1.8 - $2.83 $74,615 - $117,311	41,453 Added 335.33%	53,815 $104,000
Q4 2022 Feb 09, 2023	SELL	$2.05 - $5.5 $90,737 - $243,441	-44,262 Reduced 78.17%	12,362 $30,000
Q3 2022 Nov 10, 2022	BUY	$0.94 - $5.99 $16,459 - $104,884	17,510 Added 44.77%	56,624 $280,000
Q2 2022 Jul 26, 2022	BUY	$3.2 - $5.69 $125,164 - $222,558	39,114 New	39,114 $183,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.